| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 04/02/2008 | CN101152294A Traditional Chinese medicine soft capsule and its preparing method |
| 04/02/2008 | CN101152281A Compound rhodamine oil soft capsule and method for preparing the same |
| 04/02/2008 | CN101152277A Medicament for improving immunity function of upper enteron |
| 04/02/2008 | CN101152266A Traditional Chinese medicine preparations and use of the same |
| 04/02/2008 | CN101152258A Traditional Chinese medicine for treating stomach weakness of pregnancy hyperemesis |
| 04/02/2008 | CN101152245A Traditional Chinese medicine preparation for treating icteric viral hepatitis |
| 04/02/2008 | CN101152240A Quality detecting method for traditional Chinese medicine of astragalus membranacus |
| 04/02/2008 | CN101152239A Technique of preparing drone pupa freeze-dried powder medicinal granules and capsule |
| 04/02/2008 | CN101152237A Method of preparing kudzu root flavone chewing chips |
| 04/02/2008 | CN101152229A Notoginseng total saponin orally disintegrating tablets and method for preparing the same |
| 04/02/2008 | CN101152224A Traditional Chinese medicine for treating archoptosis |
| 04/02/2008 | CN101152211A Dachengqi tang animal blood plasma freeze-dried powder and method for preparing the same |
| 04/02/2008 | CN101152205A Inosine injection and method of preparing the same |
| 04/02/2008 | CN101152197A Compound glycyrrhizin dropping pills and method for preparing the same |
| 04/02/2008 | CN101152190A Orally disintegrating tablets of adefovir dipivoxil and method for preparing the same |
| 04/02/2008 | CN101152189A Polyene phosphatidyl choline injection and method for preparing the same |
| 04/02/2008 | CN101152168A Isoliquirtigenin capsule for treating gastrospasm |
| 04/02/2008 | CN101152156A Domperidone orally disintegrating tablets and method for preparing the same |
| 04/02/2008 | CN101152145A Sugar-free type armillarisin oral solution |
| 04/02/2008 | CN100378223C Pylorus screw bacterium fenestra element having adhesion function |
| 04/02/2008 | CN100378219C Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor |
| 04/02/2008 | CN100378214C Probiotic bacterium: lactobacillus fermentum |
| 04/02/2008 | CN100378125C Bionic affinity purifying process of interleukin I natural agonist |
| 04/02/2008 | CN100378108C Novel tetracyclic arylsulfonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 04/02/2008 | CN100378100C Pyrazolo(4,3-d)pyrimidine derivatives |
| 04/02/2008 | CN100378095C Substituted indoles as alpha-1 agonists |
| 04/02/2008 | CN100378093C Method for preparing optical purity or optically concentrated sulfoxide compounds comprising amorphous esomeprazole and its salts |
| 04/02/2008 | CN100378083C Carboxylic acid compounds and drugs containing the compounds as the active ingredient |
| 04/02/2008 | CN100378064C Active metabolic product of phencynonate and its medicinal use |
| 04/02/2008 | CN100377735C Ganoderma lucidum buccal tablet |
| 04/02/2008 | CN100377733C Method for producing yin nourishing and life strengthening oral liquor medicine |
| 04/02/2008 | CN100377723C Application of fleece flower root in preparing medicine for treating fatty liver |
| 04/02/2008 | CN100377712C Cucurbitacin lipsome preparation method and formulation |
| 04/01/2008 | US7351875 Using recombinant rodent which expresses Fc gamma RIIa receptor as tool in identifying modulators for treatment and prevention of arthritic and autoimmune disorders |
| 04/01/2008 | US7351822 Serine protease inhibitors |
| 04/01/2008 | US7351800 Stabilized albumin preparations |
| 04/01/2008 | US7351737 4-[(8-substituted)-6-chromanoyl]-and 4-[8-substituted)-chroman-6-YL-ethynyl]-benzoic and phenylacetic acids, their esters and salts having cytochrome P450RAI inhibitory activity |
| 04/01/2008 | US7351728 peroxisome proliferator activated receptor modulators; diabetes mellitus; side effects reduction; 2-Methyl-2-{4-[2-(5-methyl-2-phenyloxazol-4-yl)ethoxy]phenoxy}propionic acid; Syndrome X, Type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis |
| 04/01/2008 | US7351725 For therapy of immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection |
| 04/01/2008 | US7351723 aqueous solution with ethylenediaminetetraacetic acid and sodium hydroxide and, or sodium carbonate; regenerated for injection |
| 04/01/2008 | US7351722 for the preventive or curative treatment of hepatocellular deficiency |
| 04/01/2008 | US7351707 Spiroazacyclic compounds as monoamine receptor modulators |
| 04/01/2008 | US7351705 Carboxylic acid compounds and a pharmaceutical agent comprising the compound as the active ingredient |
| 04/01/2008 | US7351703 Which modulate the endogenous production of cyclic guanosine monophosphate (cGMP); for therapy and prophylaxis of cardiovascular disorders such as high blood pressure, angina pectoris, cardiac insufficency, thromboses, and/or atherosclerosis |
| 04/01/2008 | US7351702 Caspase inhibitors and uses thereof |
| 04/01/2008 | US7351695 Topiramate sodium, topiramate lithium, topiramate potassium, or polymorphs, solvates, hydrates, dehydrates, co-crystals, anhydrous, and amorphous forms; seizures, obesity, neuropathic pain, affective disorders, tobacco cessation, chronic fatigue syndrome, drug addiction; highly soluble, bioavailability |
| 04/01/2008 | CA2446574C Liquid pharmaceutical composition |
| 04/01/2008 | CA2298974C Thiazolobenzoheterocycles, preparation and medicines containing same |
| 03/27/2008 | WO2008036211A1 Prodrugs of proton pump inhibitors including the (1h-pyrrol-1-yl)-1h-benzimidazole moiety |
| 03/27/2008 | WO2008036201A1 Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety |
| 03/27/2008 | WO2008036022A1 Tetrahydro-lh-pyrido[3,4-b] indole derivatives as cb1 receptor ligands |
| 03/27/2008 | WO2008036021A1 Tetrahydro-lh-pyrido [3,4 -b] indole derivatives as cbl receptor ligands |
| 03/27/2008 | WO2008035816A1 Promoter of hard tissue regeneration |
| 03/27/2008 | WO2008035757A1 Jelly-like food containing ubiquinol |
| 03/27/2008 | WO2008035195A1 Benzimidazole derivatives as selective acid pump inhibitors |
| 03/27/2008 | WO2008034815A1 Combination of nmda- receptor ligand and a compound with 5-ht6 receptor affinity |
| 03/27/2008 | WO2008012089A3 Polyphenol/peptide composition and use thereof for promoting gastric health |
| 03/27/2008 | WO2007136573A3 Antidiabetic bicyclic compounds |
| 03/27/2008 | WO2007071394A3 Combination of a 5-ht4 agonist with a cholinesterase inhibitor |
| 03/27/2008 | WO2003075845A3 Immunogenicity of glucan binding protein |
| 03/27/2008 | US20080076943 4-(Hydroxymethyl)-2,6-dimethoxyphenylboronic acid chemical intermediate for preparing corticotropin-releasing factor receptor antagonists |
| 03/27/2008 | US20080076918 Quinoxaline compounds |
| 03/27/2008 | US20080076827 Treatment of Inflammatory Bowel Disease |
| 03/27/2008 | US20080076815 Sulfonamide or sulfonimide functional indazole or indole compounds such as N-[3-[2-[2-(3-methylindazol-6-yloxy)ethylamino]-1-hydryoxyethyl]phenyl]methanesulfonamide; diabetes, obesity, hyperlipidemia and urinary incontinence |
| 03/27/2008 | US20080076814 Hexahydro-Cyclooctyl Pyrazole Cannabinoid Modulators |
| 03/27/2008 | US20080076795 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators |
| 03/27/2008 | US20080076759 Therapeutic Heterocyclic Compounds 507 |
| 03/27/2008 | US20080076757 Medicine for treating gastrointestinal disorder including irritable bowel syndrome |
| 03/27/2008 | US20080076744 Method for treating inflammatory conditions with progesterone or progesterone analogs |
| 03/27/2008 | US20080076715 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 03/27/2008 | US20080075773 Solid oral composition comprising 3-(5-methoxy-1H-indol-3-yl-methylene)-N-pentylcarbazimidamide or salt and disintegrant comprising crospovidone, sodium starch glycolate, carboxymethylcellulose sodium, sodium alginate; for administering active agents which are poorly soluble in water or acid sensitive |
| 03/27/2008 | US20080075740 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor |
| 03/27/2008 | US20080075737 inducing an immune response to an HIV antigen; genetic engineered polypeptide; inserted into cell; improves or restores the blood clotting time, blood disorders; gene therapy |
| 03/27/2008 | US20080075729 ras-mediated; administering immunosuppressive for immune constituents that may interfere with the systemic delivery of the reovirus; antiproliferative; in the neoplastic cells phosphorylation of PKR is prevented by inactivation or deletion of PKR; antitumor agents |
| 03/27/2008 | US20080075728 Combination Therapies Of Hmgb And Complement Inhibitors Against Inflammation |
| 03/27/2008 | US20080075727 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 03/27/2008 | US20080075721 Method of treating fibrosis |
| 03/27/2008 | US20080075713 isomerase enzymes and ATP-binding cassette (ABC) transport proteins, used for controlling metabolism of triglycerides; diagnosis, prevention and treatment of metabolic disorders |
| 03/27/2008 | US20080075696 Treatment Of Hepatitis C In The Asian Population With Interferon-Beta |
| 03/27/2008 | US20080075688 open-cell foams useful for sequestering lipophilic materials present in the intestines or stomach, and for reducing side effects of lipase inhibitors; treatment of diarrhea |
| 03/27/2008 | DE202007014139U1 Mittel zur äußerlichen und/oder innerlichen Anwendung Means for external and / or internal use |
| 03/27/2008 | DE102006044448A1 Gelartiges Basenpräparat zur Supplementierung von Spurenelementen und Verfahren zu dessen Herstellung Gel-base preparation for supplementation of trace elements and process for its production |
| 03/27/2008 | CA2663269A1 Combination of nmda-receptor ligand and a compound with 5-ht6 receptor affinity |
| 03/26/2008 | EP1903057A2 Lipoprotein-regulating medicaments |
| 03/26/2008 | EP1903041A2 Polymorphic and other crystalline forms of cis-FTC |
| 03/26/2008 | EP1902733A1 Combination of a NMDA-receptor ligand and a compound with 5-HT6 receptor affinity |
| 03/26/2008 | EP1902730A1 Npy y2 agonist for use as therapeutic agent for disease accompanied by diarrhea |
| 03/26/2008 | EP1902729A1 Int6 PROTEIN INVOLVED IN HYPOXIA STRESS INDUCTION AND USE THEREOF |
| 03/26/2008 | EP1902715A2 Use of paliperidone for the treatment of psychiatric patients with reduced hepatic function |
| 03/26/2008 | EP1902714A1 Prodrugs of gaba analogs, compositions and uses thereof |
| 03/26/2008 | EP1901765A1 Intralesional treatment of psoriasis |
| 03/26/2008 | EP1901734A2 Compositions comprising crystalline trans-(+/-)-delta-9-tetrahydrocannabinol |
| 03/26/2008 | EP1901702A1 Ionic complexes |
| 03/26/2008 | EP1527075B1 Diazabicyclononane and -decane derivatives and their use as opioid receptor ligands |
| 03/26/2008 | EP1467997B1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
| 03/26/2008 | EP1455790B1 Use of pyridine-2,4-dicarboxylic acid diamides and of pyrimidine-4,6-dicarboxylic acid diamides for selective collagenase inhibition |
| 03/26/2008 | EP1339373B1 Use of moulding compounds for producing treatment devices |
| 03/26/2008 | EP1248847B1 Irak-4: compositions and methods of use |
| 03/26/2008 | EP1229918B1 Pharmaceutical composition comprising a combination of metformin and glibenclamide |
| 03/26/2008 | EP1196396B1 Pharmacologically active compounds with two covalently linked active principles (sodium channnel blocker/p2y2 receptor agonist) for the treatment of mucosal surfaces |